Inventiva S. A. , a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases.
Inventiva Sa stock last closed at $3.36, up 1.51% from the previous day, and has increased 4.35% in one year. It has overperformed other stocks in the Biotechnology industry by 0.83 percentage points. Inventiva Sa stock is currently +119.61% from its 52-week low of $1.53, and -13.85% from its 52-week high of $3.90.
As of Apr 17, 2025, there are 95.66M IVA shares outstanding. The market capitalization of IVA is $321.43M. In the last 24 hours, 15,372 IVA shares were traded.
You need a brokerage account in order to access the NASDAQ market and buy IVA shares.
We believe that eToro is the best online stock brokerage. Here's why:
Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've selected the best brokerage, it's time to fill out some personal information so you are able to invest in IVA today.
Now that you've finished signing up on the highest rated app to buy and sell stocks, you need to deposit funds:
Check out the video below to see the process of transferring funds into your new brokerage account.
After you have decided on the best place to buy Inventiva Sa stock, it's important to analyze their stock before you invest, so you actually wrap your head around the risk as well as the opportunity.
WallStreetZen was built to help everyday investors do more accurate fundamental analysis.
You can view all of the due diligence checks on IVA's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge IVA's intrinsic value.
You can do more valuation research on IVA's stock here.
Out of 4 Equities analysts who monitor IVA, the consensus analyst rating on Inventiva Sa is a Strong Buy
It's important to keep in mind that analyst forecasts are not recommendations, nor are they investment advice.
You can dig deeper into what analysts are projecting on the Inventiva Sa stock forecast page.
Last year, IVA revenue was $16.36M. Over the last five year, IVA's revenue has grown by 3.87% per year. This was slower than the Biotechnology industry average of 44.43%.
Dive into IVA's earnings and revenue performance here.
Over the last 12 months, insiders at IVA have not bought or sold any shares.
Get more info about who owns IVA stock here.
No, Inventiva Sa doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other traders have to say.
There are two primary options:
Hit the Open button and your broker will execute your order.
If you want additional help buying stocks on eToro, watch the how to video below:
Now that you own some IVA shares, you'll want to keep up with your new investment.
Add IVA to a watchlist to monitor your IVA stock.
To reiterate, here are the 6 steps to buy stock in Inventiva Sa:
If you need a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to watch your new investment in Inventiva Sa, create a watchlist today.